Apollo Hospitals (APOLLOHOSP)

FairStock Score: 53/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Market leadership in private healthcare with Rs 1.1L Cr market cap
• Strong profit acceleration at 38.7% growth rate
• Decent capital efficiency with 16.6% ROCE

Concerns

• Elevated P/E ratio of 61.9 vs historical healthcare norms
• Very low dividend yield of 0.2% indicating high reinvestment needs
• DhanIQ score of 3/10 suggests overvaluation concerns

AI Analysis

Apollo Hospitals is a Stalwart company — India's largest private healthcare chain with a market cap of Rs 1.1 lakh crore. The data indicates strong operational momentum with profit growth accelerating to 38.7% and sales growth at 17.2%, suggesting the company is capitalizing on India's expanding healthcare needs. However, the current P/E ratio of 61.9 is significantly elevated compared to historical norms for healthcare companies, indicating investors are paying a premium for future growth expectations. The ROCE of 16.6% demonstrates decent capital efficiency, though not exceptional for a market leader. With a dividend yield of just 0.2%, the company is clearly prioritizing reinvestment over shareholder payouts. The DhanIQ score of 3 out of 10 reflects concerns about valuation despite strong fundamentals. Analysis suggests that while Apollo maintains its market leadership position and shows acceleration potential through expansion and digital healthcare initiatives, the current pricing may have already factored in much of the near-term growth story. Investors may consider monitoring whether the company can sustain this earnings momentum to justify the premium valuation, particularly as competition intensifies in the private healthcare space.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer